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Introduction
Cesarean scar pregnancy, where the gestational sac
implants into the scar of a previous cesarean section
[1], is a rare but dangerous form of ectopic pregnancy.
It can lead to catastrophic complications, including
significant maternal morbidity or death [2]. In the past,
it was usual for the diagnosis to be made late in the first
trimester, and to be confirmed only after hysterectomy
for uncontrollable, sometimes life-threatening, hemor-
rhage from the eroded blood vessels within the myo-
metrial tissue [3]. Cesarean scar pregnancy must be
distinguished from other types of abnormally implanted
pregnancies, including cervical, cervico-isthmic, and
cervico-isthmic-corporeal pregnancies, to ensure opti-
mal treatment and patient outcome. Conservative
management of these pregnancies has been proposed
under stable clinical conditions. This includes amniotic
aspiration with local potassium chloride and/or
methotrexate administration [1,4]. Recent advances in
the resolution of transvaginal and color Doppler
ultrasonography has made it possible to diagnose ectopic
pregnancies as early as possible. We describe a case of
ectopic pregnancy in a cesarean scar that was diagnosed
by transvaginal ultrasonography, and managed
successfully with intramuscular methotrexate injection
followed by suctional curettage.
Case Report
A 28-year-old, gravida 3, para 2, woman with a history
of previous cesarean section presented to her local
obstetrician with vaginal bleeding after 6 weeks’
amenorrhea. A pregnancy test was positive. Ultrasound
identified a gestational sac in the lower segment of the
uterus. Suspected to have a cervical pregnancy of 6
weeks’ gestation, she was referred to our hospital where
pelvic examination on arrival showed a normal-sized
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uterus with nodularity and a closed cervical os. Trans-
vaginal ultrasound showed a single viable fetus with
a crown–rump length of 2.8 mm in a gestational sac
implanted in the lower segment of the uterus (Figure 1).
A diagnosis of cesarean scar pregnancy was made.
A single dose of systemic methotrexate 50 mg was
given intramuscularly. Ten days later, repeat ultrasono-
graphy showed a yolk sac in a gestational sac measuring
24 = 16 = 22 mm (Figure 2). The serum level of ` -human
chorionic gonadotropin (`-hCG) was 82,937 mIU/mL.
Based on the ultrasound findings and serum `-hCG,
suctional curettage was performed to remove the
gestational sac; the pathology report revealed products
of conception. One week later, serum `-hCG was 1,252
mIU/mL. After another 10 days, repeat sonography
revealed a mass measuring 21.9 = 20.4 mm, as well as
diminished blood flow at the isthmus of the uterus on
Doppler examination (Figure 3). Serum ` -hCG returned to normal 21 days after suctional curettage. Although
the patient suffered from persistent vaginal spotting for
2 months, there were no major complications noted at
follow-up.
Discussion
Cesarean scar pregnancy is an extremely rare type of
ectopic pregnancy, with a high risk of uterine rupture
and uncontrollable hemorrhage [5,6]. Its incidence
may have increased due to the greater number of cesarean
sections being performed. Larsen and Solomon reported
the first case of cesarean scar pregnancy in 1978, and
successfully treated it with laparotomy, hysterotomy
resection, and uterine scar dehiscence repair [7]. Several
clinicians have successfully treated cervical scar
pregnancy by using systemic methotrexate as primary
treatment [8–12].
The exact cause of cesarean scar pregnancy remains
unknown. Many obstetricians believe that its occurrence
in the myometrium is due to the existence of microtubules
that allow implantation of the gestational sac into the
myometrium [1]. The formation of microtubules may
arise due to a previous cesarean section, a previous
dilatation and curettage, adenomyosis or history of in
vitro fertilization treatment [1,13–17]. Damage to the
endometrium in cesarean sections also damages the
decidua basalis, thus facilitating the embedding and
growth of trophocytes in the myometrium [1].
Accurate diagnosis of cesarean scar pregnancy re-
lies on a high index of suspicion and high-resolution
transvaginal sonography, which facilitates the diagnosis
of an ectopic pregnancy in a uterine scar with regards to
location, age, size and viability. Strict ultrasound imag-
ing criteria must be used: empty uterus, empty cervical
Figure 1. (A) Transvaginal ultrasound shows an early gestational
sac implanted at the anatomic location of a previous cesarean
section scar (thick arrow); a single viable fetus with a crown–
rump length of 2.8 mm is seen within the sac (thin arrows).
(B) Power Doppler imaging of the same area shows vasculari-
zation of the gestational sac. CX = cervix; F = fundal endo-
metrial cavity.
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Figure 2. (A) Transvaginal ultrasound shows the persistence of
the ectopic gestational sac, measuring 24 = 16 = 22 mm (thin
arrows), after treatment with methotrexate (the thick arrow
indicates the cesarean section scar). (B) Power Doppler imaging
of the same area. CX = cervix; F = fundal endometrial cavity.
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Figure 3. (A) Transvaginal ultrasound shows a 20.4 = 21.9 mm
mass (arrows) after treatment with suctional curettage.
(B) Power Doppler imaging of the same area shows dimin-
ished blood flow in the mass. CX = cervix; F = fundal endo-
metrial cavity.
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canal, development of the sac in the anterior part of the
isthmic portion, and thinning or complete absence of
healthy myometrium between the bladder and the sac;
the last criterion allows differentiation from cervico-
isthmic implantation [4,10,17,18]. In addition, `-hCG
assays will aid in earlier diagnosis.
Dilatation and curettage (D&C) has been described
as a treatment for cesarean scar pregnancy when the
location of the gestational sac was misdiagnosed [5,
17]. D&C is a contraindication in cesarean scar ectopic
pregnancy as it may cause uterine perforation, induc-
ing intractable bleeding, and laparotomy or even
hysterectomy is often required [10,19–21]. Lee et al
reported the first case of an ectopic pregnancy in a
previous cesarean section scar to be diagnosed by
ultrasound and hysteroscopy, and managed successfully
by operative laparoscopy [22].
Conservative management of cesarean scar preg-
nancies has been proposed. Lai et al reported that in-
tramuscular injections of methotrexate could have a
better curative effect [1]; Godin et al suggested amnio-
tic aspiration with local administration of potassium
chloride and/or methotrexate directly into the gesta-
tional sac and surrounding myometrium [4]; Roberts et
al injected hypertonic glucose into the ectopic sac using
direct ultrasound needle guidance, supported by short-
term administration of oral methotrexate [23]; Seow et
al used local injection of methotrexate under ultrasound
guidance [17].
In our case, we aimed to preserve our patient’s
fertility with conservative management. Intramuscular
systemic methotrexate was first given to reduce the
activity of trophoblastic cells. Then, a suctional curettage
was performed successfully. Great attention was paid to
any vaginal bleeding and vital signs as the patient might
be threatened with massive vaginal bleeding and uterine
rupture; if any uncontrolled bleeding had happened,
emergency surgery, such as hysterectomy, might have
had to be performed.
Indeed, methotrexate is simple and highly effective
[24,25], even if various side effects have been described
[26]. Systemic methotrexate administration followed
by expectant management has been suggested as an
alternative method of treatment in early or nonviable
ectopic pregnancy embedded in a uterine scar [27]. This
is in accordance with the treatment suggested for viable
7-week uterine scar gestation [9] and cornual pregnancy
[28].
In conclusion, systemic intramuscular methotrexate
followed by suctional curettage may be a safe treatment
alternative for cesarean scar pregnancies [27] if there
are no contraindications for patients who desire to
preserve fertility [10].
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